Skip to content
Protagonist Therapeutics Inc icon

Protagonist Therapeutics Inc

PTGXStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$144.48

Today

+0.5%

YTD

+65.8%

About

Protagonist Therapeutics is a healthcare company based in Newark, California, US and established in 1996. Operating locally, the company aims to meet as-yet-unmet medical requirements through the use of peptide drugs. It is traded on the NASDAQ GM under the stock ticker PTGX. PTGX stock is available on eToro. Learn more now!

Price chart
Closing price history for PTGX (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)135.60
P/S (TTM)35.41
P/B (TTM)10.81
Market cap$9.10B
Cap tierMid-cap
Industry avg P/E-7.40

Profitability

Gross margin99.45%
EBIT margin20.69%
Net margin76.28%
ROE10.98%
ROA10.34%

Earnings & Revenue

Revenue (TTM)$281.99M
Revenue growth (1Y)+34.8%
EPS (TTM)$1.04
Free cash flow$130.58M
Total debt$9.22M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.57
Employees132
Next earnings5 Nov '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

Protagonist Therapeutics Inc (PTGX) | Dirk Kuyken